The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Point of Care Testing for Infectious Disease Market Research Report 2024

Global Point of Care Testing for Infectious Disease Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1885820

No of Pages : 81

Synopsis
The global Point of Care Testing for Infectious Disease market was valued at US$ 10280 million in 2023 and is anticipated to reach US$ 13440 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
North American market for Point of Care Testing for Infectious Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Point of Care Testing for Infectious Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Point of Care Testing for Infectious Disease in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Point of Care Testing for Infectious Disease include Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY and Sinocare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Point of Care Testing for Infectious Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care Testing for Infectious Disease.
Report Scope
The Point of Care Testing for Infectious Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Point of Care Testing for Infectious Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care Testing for Infectious Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Sinocare
Wondfo
Yuwell
Runbio
KHB
Segment by Type
Immunological Test
Pathogen Nucleic Acid Test
Segment by Application
Hospital
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point of Care Testing for Infectious Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Testing for Infectious Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunological Test
1.2.3 Pathogen Nucleic Acid Test
1.3 Market by Application
1.3.1 Global Point of Care Testing for Infectious Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Testing for Infectious Disease Market Perspective (2019-2030)
2.2 Point of Care Testing for Infectious Disease Growth Trends by Region
2.2.1 Global Point of Care Testing for Infectious Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Point of Care Testing for Infectious Disease Historic Market Size by Region (2019-2024)
2.2.3 Point of Care Testing for Infectious Disease Forecasted Market Size by Region (2025-2030)
2.3 Point of Care Testing for Infectious Disease Market Dynamics
2.3.1 Point of Care Testing for Infectious Disease Industry Trends
2.3.2 Point of Care Testing for Infectious Disease Market Drivers
2.3.3 Point of Care Testing for Infectious Disease Market Challenges
2.3.4 Point of Care Testing for Infectious Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Testing for Infectious Disease Players by Revenue
3.1.1 Global Top Point of Care Testing for Infectious Disease Players by Revenue (2019-2024)
3.1.2 Global Point of Care Testing for Infectious Disease Revenue Market Share by Players (2019-2024)
3.2 Global Point of Care Testing for Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care Testing for Infectious Disease Revenue
3.4 Global Point of Care Testing for Infectious Disease Market Concentration Ratio
3.4.1 Global Point of Care Testing for Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Testing for Infectious Disease Revenue in 2023
3.5 Point of Care Testing for Infectious Disease Key Players Head office and Area Served
3.6 Key Players Point of Care Testing for Infectious Disease Product Solution and Service
3.7 Date of Enter into Point of Care Testing for Infectious Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Testing for Infectious Disease Breakdown Data by Type
4.1 Global Point of Care Testing for Infectious Disease Historic Market Size by Type (2019-2024)
4.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size by Type (2025-2030)
5 Point of Care Testing for Infectious Disease Breakdown Data by Application
5.1 Global Point of Care Testing for Infectious Disease Historic Market Size by Application (2019-2024)
5.2 Global Point of Care Testing for Infectious Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Point of Care Testing for Infectious Disease Market Size (2019-2030)
6.2 North America Point of Care Testing for Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Point of Care Testing for Infectious Disease Market Size by Country (2019-2024)
6.4 North America Point of Care Testing for Infectious Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Testing for Infectious Disease Market Size (2019-2030)
7.2 Europe Point of Care Testing for Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Point of Care Testing for Infectious Disease Market Size by Country (2019-2024)
7.4 Europe Point of Care Testing for Infectious Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Testing for Infectious Disease Market Size (2019-2030)
8.2 Asia-Pacific Point of Care Testing for Infectious Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Point of Care Testing for Infectious Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care Testing for Infectious Disease Market Size (2019-2030)
9.2 Latin America Point of Care Testing for Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Point of Care Testing for Infectious Disease Market Size by Country (2019-2024)
9.4 Latin America Point of Care Testing for Infectious Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Testing for Infectious Disease Market Size (2019-2030)
10.2 Middle East & Africa Point of Care Testing for Infectious Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Point of Care Testing for Infectious Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Point of Care Testing for Infectious Disease Introduction
11.1.4 Roche Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Point of Care Testing for Infectious Disease Introduction
11.2.4 Abbott Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 LifeScan
11.3.1 LifeScan Company Detail
11.3.2 LifeScan Business Overview
11.3.3 LifeScan Point of Care Testing for Infectious Disease Introduction
11.3.4 LifeScan Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.3.5 LifeScan Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point of Care Testing for Infectious Disease Introduction
11.4.4 Siemens Healthineers Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.4.5 Siemens Healthineers Recent Development
11.5 Danaher
11.5.1 Danaher Company Detail
11.5.2 Danaher Business Overview
11.5.3 Danaher Point of Care Testing for Infectious Disease Introduction
11.5.4 Danaher Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.5.5 Danaher Recent Development
11.6 Ascensia
11.6.1 Ascensia Company Detail
11.6.2 Ascensia Business Overview
11.6.3 Ascensia Point of Care Testing for Infectious Disease Introduction
11.6.4 Ascensia Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.6.5 Ascensia Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Detail
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Point of Care Testing for Infectious Disease Introduction
11.7.4 BioMerieux Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.7.5 BioMerieux Recent Development
11.8 ARKRAY
11.8.1 ARKRAY Company Detail
11.8.2 ARKRAY Business Overview
11.8.3 ARKRAY Point of Care Testing for Infectious Disease Introduction
11.8.4 ARKRAY Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.8.5 ARKRAY Recent Development
11.9 Sinocare
11.9.1 Sinocare Company Detail
11.9.2 Sinocare Business Overview
11.9.3 Sinocare Point of Care Testing for Infectious Disease Introduction
11.9.4 Sinocare Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.9.5 Sinocare Recent Development
11.10 Wondfo
11.10.1 Wondfo Company Detail
11.10.2 Wondfo Business Overview
11.10.3 Wondfo Point of Care Testing for Infectious Disease Introduction
11.10.4 Wondfo Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.10.5 Wondfo Recent Development
11.11 Yuwell
11.11.1 Yuwell Company Detail
11.11.2 Yuwell Business Overview
11.11.3 Yuwell Point of Care Testing for Infectious Disease Introduction
11.11.4 Yuwell Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.11.5 Yuwell Recent Development
11.12 Runbio
11.12.1 Runbio Company Detail
11.12.2 Runbio Business Overview
11.12.3 Runbio Point of Care Testing for Infectious Disease Introduction
11.12.4 Runbio Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.12.5 Runbio Recent Development
11.13 KHB
11.13.1 KHB Company Detail
11.13.2 KHB Business Overview
11.13.3 KHB Point of Care Testing for Infectious Disease Introduction
11.13.4 KHB Revenue in Point of Care Testing for Infectious Disease Business (2019-2024)
11.13.5 KHB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’